639 related articles for article (PubMed ID: 19258584)
1. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
Ho PM; Maddox TM; Wang L; Fihn SD; Jesse RL; Peterson ED; Rumsfeld JS
JAMA; 2009 Mar; 301(9):937-44. PubMed ID: 19258584
[TBL] [Abstract][Full Text] [Related]
2. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
[TBL] [Abstract][Full Text] [Related]
3. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.
Wu CY; Chan FK; Wu MS; Kuo KN; Wang CB; Tsao CR; Lin JT
Gastroenterology; 2010 Oct; 139(4):1165-71. PubMed ID: 20600012
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.
Lin CF; Shen LJ; Wu FL; Bai CH; Gau CS
Br J Clin Pharmacol; 2012 Nov; 74(5):824-34. PubMed ID: 22364155
[TBL] [Abstract][Full Text] [Related]
6. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
7. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM;
Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792
[TBL] [Abstract][Full Text] [Related]
8. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
9. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.
Ho PM; Peterson ED; Wang L; Magid DJ; Fihn SD; Larsen GC; Jesse RA; Rumsfeld JS
JAMA; 2008 Feb; 299(5):532-9. PubMed ID: 18252883
[TBL] [Abstract][Full Text] [Related]
10. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
Bhurke SM; Martin BC; Li C; Franks AM; Bursac Z; Said Q
Pharmacotherapy; 2012 Sep; 32(9):809-18. PubMed ID: 22744772
[TBL] [Abstract][Full Text] [Related]
11. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
Weisz G; Smilowitz NR; Kirtane AJ; Rinaldi MJ; Parvataneni R; Xu K; Stuckey TD; Maehara A; Witzenbichler B; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Stone GW
Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26458411
[TBL] [Abstract][Full Text] [Related]
13. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
14. Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: results from two distinct patient populations.
Ernst FR; Johnston S; Curkendall S; Mozaffari E; Stemkowski S
Am J Health Syst Pharm; 2011 Jun; 68(11):1015-24. PubMed ID: 21593230
[TBL] [Abstract][Full Text] [Related]
15. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
17. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
[TBL] [Abstract][Full Text] [Related]
18. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
[TBL] [Abstract][Full Text] [Related]
19. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
[TBL] [Abstract][Full Text] [Related]
20. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.
Gaglia MA; Torguson R; Hanna N; Gonzalez MA; Collins SD; Syed AI; Ben-Dor I; Maluenda G; Delhaye C; Wakabayashi K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):833-8. PubMed ID: 20211327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
